| 000 | 00904 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250514210619.0 | ||
| 264 | 0 | _c20050329 | |
| 008 | 200503s 0 0 fre d | ||
| 022 | _a0761-8417 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBréchot, J-M | |
| 245 | 0 | 0 |
_a[The place of targeted treatments: receptor tyrosine kinase inhibitors]. _h[electronic resource] |
| 260 |
_bRevue de pneumologie clinique _cNov 2004 |
||
| 300 |
_a3S68-71 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
| 773 | 0 |
_tRevue de pneumologie clinique _gvol. 60 _gno. 5 Pt 2 _gp. 3S68-71 |
|
| 999 |
_c15223679 _d15223679 |
||